Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma

Background: The aims of this study were to evaluate the efficacy of additional treatment, especially lenvatinib-transarterial chemoembolization (TACE) sequential therapy, for unresectable hepatocellular carcinoma (HCC). Methods: Consecutive 56 patients who underwent lenvatinib treatment were reviewe...

Full description

Bibliographic Details
Main Authors: Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Licht Tominaga, Akira Kajiwara, Kayoko Kasuya, Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Tokuyo Kozuka, Hiromitsu Kumada
Format: Article
Language:English
Published: Karger Publishers 2020-10-01
Series:Liver Cancer
Subjects:
hepatocellular carcinoma
lenvatinib
oncological aggressiveness
subsequent treatment
lenvatinib-transarterial chemoembolization sequential therapy
Online Access:https://www.karger.com/Article/FullText/510299

Internet

https://www.karger.com/Article/FullText/510299

Similar Items